Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Urology|December 1, 1975
Effect of hormone therapy on immune response in patients with prostatic cancerP D Guinan, R J Ablin, S Nourkayhan, et al.National Cancer Institute Monograph|December 1, 1978
The carcinoembryonic antigen test in urologic cancerP D Guinan, C McKiel, B Sundar, et al.Lupus|September 4, 2010
The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stressZ Ergaz, D Mevorach, G Goldzweig, et al.Urology|February 1, 1976
Immunostaging in carcinoma of prostateP D Guinan, R J Ablin, E R Rios, et al.The Journal of Laboratory and Clinical Medicine|February 1, 1976
Hormonal therapy and alteration of lymphocyte proliferationR J Ablin, G R Bruns, P D Guinan, et al.Urology|February 1, 1979
Effect of transurethral resection on coagulation in carcinoma of prostateV Betkurer, P Guinan, A Verma, et al.European Urology|January 1, 1979
Modulatory effects of oestrogen on immunologic responsiveness. I. Inhibition of DNA synthesis in peripheral blood lymphocytes from patients with Peyronie's disease, prostatic cancer and transsexuals and a commentaryR J Ablin, G R Bruns, P D Guinan, et al.Gene Therapy|June 25, 2002
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer modelM K Nyati, Z Symon, E Kievit, et al.American Journal of Surgery|May 1, 1976
Impotence therapy and cancer of the prostateP D Guinan, W Sadoughi, H Alsheik, et al.Experientia|March 15, 1980
Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasmaR A Bhatti, R J Ablin, S Zamora, et al.Pageof 14